ECPC has been invited toparticipate in one of the most prestigious European research programs, namely TRANSCAN 2. TRANSCAN is aEuropean Research Area Network – ERA-NET funded by the European Commission under the Seventh Framework Programme (FP7).
TRANSCAN is a collaborative network of ministries, funding agencies and research councils with programmes in translational cancer research. The network is composed of 25 partners from 19 European and Associated countries.
TRANSCAN aims at linking translational cancer research funding programmes of 25 organisations from 19 Member States and Associated Countries. By converging national resources, TRANSCAN will establish critical financial and scientific mass for tackling large-scale questions relevant to improving translational cancer research in Europe.
TRANSCAN will contribute to the building of the European Research Area through the coordination of activities of national and regional translational cancer research funding organisations, aiming at the integration of basic, clinical and epidemiological cancer research and facilitation of transnational cancer funding in Europe with the ultimate aim to streamline EU-wide cancer screening, early diagnosis, prognosis, treatment and care.
ECPC is represented in the Scientific Advisory Board (SAB), one of the three main governing bodies of the network. The SAB serves as a source of input on and feedback about the work of TRANSCAN and is in close collaboration with the other two bodies: the Network Steering Committee (NSC), as the strategic decision-making body and the Network Coordination Unit (NCU), as the body responsible for the day-to-day management and the external TRANSCAN consortium representation.